Nanotechnology and Therapeutic Interventions in COVID–19: A Review

Hire Gauri *

Department of Quality Assurance, PRE’S College of Pharmacy (for Women) Chincholi, Nashik, Maharashtra, India.

Bhangale Charushila

Department of Pharmaceutical Chemistry, PRE’S College of Pharmacy (for Women) Chincholi, Nashik, Maharashtra, India.

*Author to whom correspondence should be addressed.


The topic and title concern the modern technology study and review with the aid and aiming the therapeutic interpretation and overall emphases on a novel corona virus disease called COVID-19, a respiratory disorder; to overcome the disease and its prevention, the article is determined here. As the modern technique to demonstrate the overview of the virus and its cause, prevention, treatment and how the so-called modern technique, namely “nanotechnology” and its various components and factors are valuable and helpful with their pharmacological effects, implications, and other therapeutic interventions in treating the viral infection is discussed and reviewed. Several essential factors with nanoparticles, nanomaterials, and technology-based applications by reduction of spreadability of infections with nanoformulation antibiotics and pharmaceuticals are demonstrated in the article. For increased patient and healthcare worker safety, nano-based antimicrobial technologies are included too. Again binding, entrance, replication, and budding of COVID-19 can be targeted by the antiviral properties of nanoparticles which is actual need of the study. One factor that restricts its use and should be further researched and altered is the toxicity-related inorganic nanoparticles observed and need to investigate further for vigilance, one must say. The article describes several facts about nanotechnology in treating and preventing infection and its therapeutic interventions.

Keywords: Nanotechnology, therapeutic interventions, Covid-19, nanoparticles, nanomaterials

How to Cite

Gauri, H. and Charushila, B. (2024) “Nanotechnology and Therapeutic Interventions in COVID–19: A Review”, Journal of Pharmaceutical Research International, 36(6), pp. 144–154. doi: 10.9734/jpri/2024/v36i67530.


Download data is not yet available.


Palani R, Annadurai K, Nachiyar G. Journal of Family Medicine & Medical Science Research Nanotechnology in Healthcare : An Overview; 3–4.

Grey Arora T, Thomas J, Saneh A, Tohme P, Abi-habib RI. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. Psychiatry Res. 2020;14(4)(January):293.

Bezbaruah R, Chavda VP, Nongrang L, Alom S, Deka K, Kalita T, et al. Nanoparticle-Based Delivery Systems for Vaccines. Vaccines. 2022;10(11).

Yang D. COVID-19. (2024, February 8). In Wikipedia. Vol. 16, International Journal of Nanomedicine. 2021;623–49.


Pati R, Shevtsov M, Sonawane A. Nanoparticle vaccines against infectious diseases. Front Immunol. 2018;9(OCT).

Yang KC, Lin JC, Tsai HH, Hsu CY, Shih V, Hu CMJ. Nanotechnology advances in pathogen- and host-targeted antiviral delivery: multipronged therapeutic intervention for pandemic control. Drug Deliv Transl Res. 2021;11(4):1420–37.

Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO. Nanotechnology for COVID-19: Therapeutics and Vaccine Research. ACS Nano. 2020;14(7):7760–82.

Mba IE, Sharndama HC, Osondu-chuka GO, Okeke OP. Immunobiology and nanotherapeutics of severe acute respiratory syndrome 2 (SARS-CoV-2): A current update. Infect Dis (Auckl). 2021;53(8):559–80.